| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/15/2004 | US20040009877 Hetaryl-substituted heterocycles |
| 01/15/2004 | DE10229070A1 Phenylderivate 5 Phenyl derivatives 5 |
| 01/15/2004 | CA2492121A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | CA2491998A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | CA2491994A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | CA2491673A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 01/15/2004 | CA2490463A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | CA2489166A1 Substituted anthranilic amide derivatives and methods of use |
| 01/14/2004 | EP1380562A1 Carboxylic acid derivative and salt thereof |
| 01/14/2004 | EP1380307A1 Tissue fibrosis inhibitors |
| 01/14/2004 | EP1380121A2 Process to prepare oxazolidinones |
| 01/14/2004 | EP1379525A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/14/2004 | EP1379522A1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I |
| 01/14/2004 | EP1379520A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 01/14/2004 | EP1379517A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 01/14/2004 | EP1379513A1 Prodrugs of cox-2 inhibitors |
| 01/14/2004 | EP1379511A1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
| 01/14/2004 | EP1379508A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | EP1379249A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 01/14/2004 | EP1379246A1 Nociceptin analogs |
| 01/14/2004 | EP1019385B1 Aminoaryl oxazolidinone n-oxides |
| 01/14/2004 | CN1468238A Substituted pyrazoles |
| 01/14/2004 | CN1468237A Substituted pyrazoles |
| 01/14/2004 | CN1468233A Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 01/14/2004 | CN1468232A Heterocyclic sodium/proton exchange inhibitors and method |
| 01/14/2004 | CN1468217A Aliphatic nitrogenous five-membered ring compounds |
| 01/14/2004 | CN1468216A Nitrogenous five-membered ring compounds |
| 01/14/2004 | CN1468112A The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/14/2004 | CN1134444C Epothilone analog and medicine combination |
| 01/14/2004 | CN1134434C Novel 2-heterocyclically substituted dihydropyrimidines |
| 01/14/2004 | CN1134423C Adhesion receptor antagonists |
| 01/14/2004 | CN1134421C Antifungal and its preparation method and intermediate |
| 01/14/2004 | CN1134418C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 01/14/2004 | CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 01/13/2004 | US6677452 Pyridine carboxamide or sulfonamide derivatives and combinatorial libraries thereof |
| 01/13/2004 | US6677368 4-aryl substituted indolinones |
| 01/13/2004 | US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 01/13/2004 | US6677354 Treating sleep, brain, sexual, cardiovascular, nervous system, psychological, glandular, and gastrointestinal disorders |
| 01/13/2004 | US6677339 S-3-(4-(3,5-dichloropyrid-4-ylcarboxamido)phenyl)-2-(4,6-dimet hoxy-1,3,5-triazin-2-ylamino)propanoic acid for example; inhibit binding of alpha 4 integrins to their ligands, for treating immune or inflammatory disorders |
| 01/13/2004 | US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 01/13/2004 | CA2139731C 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 01/08/2004 | WO2004003103A1 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use |
| 01/08/2004 | WO2004002977A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002967A1 Difluorothioacetamides of oxazolidinones as antibacterial agents |
| 01/08/2004 | WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 01/08/2004 | WO2004002964A1 Diaminopyrimidinecarboxa mide derivative |
| 01/08/2004 | WO2004002948A1 Amide compound and medicinal use thereof |
| 01/08/2004 | WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 01/08/2004 | WO2004002479A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents |
| 01/08/2004 | WO2004002477A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 01/08/2004 | WO2003077828A3 Novel florfenicol-type antibiotics |
| 01/08/2004 | US20040006238 As chemical intermediates for production of pharmacologically useful oxazolidinones |
| 01/08/2004 | US20040006230 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 01/08/2004 | US20040006226 Useful in therapy where cognition enhancement is required |
| 01/08/2004 | US20040006141 Amidocarboxylic acid compounds |
| 01/08/2004 | US20040006110 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 01/08/2004 | US20040006108 Useful as insecticides and acaricides |
| 01/08/2004 | US20040006107 For prophylaxis of asthma and other allergic diseases |
| 01/08/2004 | US20040006105 Thrombin receptor antagonists |
| 01/08/2004 | US20040006104 For therapy and prophylaxis of diseases and conditions associated with undesirable or abnormal inflammatory responses, such as ischemia-reperfusion injury, asthma, arthritis |
| 01/08/2004 | US20040006101 Quinolinone derivatives |
| 01/08/2004 | US20040006096 Substituted alkanohydroxamic acids and method of reducing TNFalpha levels |
| 01/08/2004 | US20040006088 Substituted N-(indole-2-carbonyl) -amides and derivatives as glycogen phosphorylase inhibitors |
| 01/08/2004 | US20040006087 Method of treating cancer using FPT inhibitors and antineoplastic agents |
| 01/08/2004 | US20040006081 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 01/08/2004 | US20040006080 Chemical compounds |
| 01/08/2004 | US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease |
| 01/08/2004 | US20040006067 Substituted piperidines and methods of use |
| 01/08/2004 | US20040006057 For therapy of connective tissue disorders, inflammatory disorders, immunology/allergy disorders, infectious diseases, respiratory diseases, cardiovascular diseases, eye diseases, metabolic diseases, central nervous system (CNS) disorders |
| 01/08/2004 | US20040006056 Substituted alkanoic acids |
| 01/08/2004 | US20040005986 Pyridazin-3-one derivatives, their use, and intermediates for their production |
| 01/08/2004 | CA2491271A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 01/08/2004 | CA2490193A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents |
| 01/08/2004 | CA2489433A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2489411A1 Difluorothioacetamides of oxazolidinones as antibacterial agents |
| 01/08/2004 | CA2488525A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377589A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377556A1 Pyrazole derivatives for treating hiv |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 01/07/2004 | EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 01/07/2004 | EP1175417B1 Substituted benzolactam compounds |
| 01/07/2004 | CN1466580A Thiazole or oxazole derivatives |
| 01/07/2004 | CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 01/07/2004 | CN1465575A Green light spectrum sensitizer, and synthesis method and use thereof |
| 01/07/2004 | CN1133635C Cyanopyrroles as progesterone receptor agonists |
| 01/07/2004 | CN1133634C Heterocyclic derivatives which inhibit factor Xa |
| 01/07/2004 | CN1133632C Process for preparation of taxanes from 10-deacetylbeccatin III |
| 01/07/2004 | CN1133625C Quinazoline derivatives |
| 01/07/2004 | CN1133622C Ureidopiperidine derivatives as selective human NK3 receptor antagonists |
| 01/07/2004 | CN1133372C Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl or pyridyl)methyl] piperidines |
| 01/06/2004 | US6673939 Process for the preparation of 1,2,4-triazolin-5-one derivatives |
| 01/06/2004 | US6673832 Determining whether a compound alleviates vasoconstriction-independent nerve pain mediated by endothelin-1 |
| 01/06/2004 | US6673829 Treatment of diseases of the central nervous system, the peripheral nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system. |
| 01/06/2004 | US6673817 Anticoagulants |
| 01/06/2004 | US6673815 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |